Companies / Brazil
Brazil's EMS Increases Focus On Off-Patent Lines
July 2006 | Company Finance AlertBrazilian drug producer EMS Sigma is to boost its product portfolio and focus on new generic lines, which already account for 49% of turnover. EMS has announced ambitious plans to launch five new products each month and boost doctor visits from company sales
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
